Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of TRO19622 administered PO
daily for 6 weeks compared to placebo administered PO daily in patients with painful
peripheral diabetic neuropathy.